The latest breast cancer news
Browsing: Breast Cancer
Gene modification can reduce the risk of breast cancer
A global study led by the University of Otago has discovered a gene, that when…
Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard…
Clues found regarding tumour suppressor gene’s breast cancer activity
Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to…
Palbociclib combination in advanced breast cancer: Again only disadvantages
Palbociclib in combination with an aromatase inhibitor is, among other therapeutic indications, approved for first-line…
SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer
Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab…
SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer
Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in…
SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced hormone receptor-positive breast cancer
In patients with hormone receptor (HR)-positive, HER2-negative tumours resistant to aromatase inhibitors, addition of the…
SABCS 2022: Treatment decision guided by CTC count may improve long-term outcomes for mBC
The use of circulating tumour cell (CTC) count to guide the choice between chemotherapy and endocrine…
SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
Long-term clinical outcomes from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx) or TAILORx trial continue to show that most…
SABCS 2022: Genetic profiling may identify patients with breast cancer who can safely omit radiation therapy after breast-conserving surgery
Patients with invasive breast cancer who had low scores on an investigational gene molecular signature had…